DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar mnsw (< 20) Submitted: 2/3/2007 3:45:21 PM : Outperform Start Price: $4.42 DRRX Score: -75.93

Pipeline is "loaded". Partnering with some of the best in the field (ENDP).

Featured Broker Partners


Advertisement